Sub-Cellular Imaging: Towards to Drug Discovery and Organelle-Targeted Therapy

A special issue of Cells (ISSN 2073-4409). This special issue belongs to the section "Cell Methods".

Deadline for manuscript submissions: closed (15 May 2023) | Viewed by 4381

Special Issue Editors

Science and Technology Innovation Center, Shandong First Medical University, Jinan 250101, China
Interests: super-resolution imaging; subcellular dynamics; organelle; drug; target; mechanism; imaging; theranostics

E-Mail Website
Guest Editor
School of Pharmaceutical Sciences, Shandong University, Jinan 250101, China
Interests: small-molecule drugs; imaging; osteoarthritis; mitochondria; biotechnology; polysaccharides; inflammation; immunity

Special Issue Information

Dear Colleagues,

The crosstalk between organelle interactions is involved in many cellular processes. For instance, mitophagy, a process that selectively removes redundant or damaged mitochondria, plays an important role in regulating the number of intracellular mitochondria and maintaining mitochondrial functions. Dysregulated organelle interactions are implicated in many diseases, such as neurodegenerative diseases and cancer. To date, organelle interactions have often been studied at the cellular level through methods such as flow cytometry, enzyme-linked immunosorbent assays, Western blotting, and confocal fluorescence microscopy. These methods only report the cumulative level of total organelles (such as lysosomes) and ignore individual organelle interaction events that occur at the fusion between individual organelles. Although confocal fluorescence microscopy can detect organelles using organelle-specific dye, it is difficult to distinguish subcellular structures at a resolution beyond 200 nm. Moreover, the electron microscope does not provide details on the interactive behavior of individual organelle microenvironments in living systems. Thus, a novel strategy is needed to capture detailed information on the organelle–organelle crosstalk. Therefore, a direct evaluation of the subcellular response after drug exposure, such as the organelle morphology, number, distribution, interactions, and bioactive substances, may be an excellent strategy for understanding the involved drug’s mechanism and target validation.

Newly developed technologies such as super-resolution imaging, which includes stimulated emission deletion (STED), structured illumination microscopy (SIM), and stochastic optical reconstruction microscopy (STORM), as well as other single-molecule super-resolution imaging techniques, are enhanced imaging tools developed for investigating the dynamics of subcellular structures. This Special Issue plans to present an overview of the most recent advances in the field of subcellular labeling and their applications in organelle-targeted labeling and therapy. The aim of this Special Issue is to introduce new technologies, models, methods, potential drugs, and imaging probes for the development of subcellular imaging. We welcome original research, reviews, and perspective articles on themes including, but not limited to: novel molecules with drug potential based on subcellular targeted therapy; new techniques such as nanoscopic imaging, optogenetics, single-molecule imaging, photodynamic therapy, new molecular biology techniques, etc. to clarify the underlying pathology of organelle-related diseases; new analytical methods for quantifying subcellular dynamics; new research models using cells, reproductive cells, zebrafish, C. elegans, or organoids for exploring subcellular functions; and novel imaging probes for subcellular tracking and organelle-related labeling and disease therapy.

Dr. Qixin Chen
Prof. Dr. Peixue Ling
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • subcellular dynamics
  • organelle
  • probe
  • imaging
  • labeling
  • theranostics

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

15 pages, 4219 KiB  
Review
Mitochondrial Unfolded Protein Response and Integrated Stress Response as Promising Therapeutic Targets for Mitochondrial Diseases
by Hedong Lu, Xiaolei Wang, Min Li, Dongmei Ji, Dan Liang, Chunmei Liang, Yajing Liu, Zhiguo Zhang, Yunxia Cao and Weiwei Zou
Cells 2023, 12(1), 20; https://doi.org/10.3390/cells12010020 - 21 Dec 2022
Cited by 13 | Viewed by 3815
Abstract
The development and application of high-throughput omics technologies have enabled a more in-depth understanding of mitochondrial biosynthesis metabolism and the pathogenesis of mitochondrial diseases. In accordance with this, a host of new treatments for mitochondrial disease are emerging. As an essential pathway in [...] Read more.
The development and application of high-throughput omics technologies have enabled a more in-depth understanding of mitochondrial biosynthesis metabolism and the pathogenesis of mitochondrial diseases. In accordance with this, a host of new treatments for mitochondrial disease are emerging. As an essential pathway in maintaining mitochondrial proteostasis, the mitochondrial unfolded protein response (UPRmt) is not only of considerable significance for mitochondrial substance metabolism but also plays a fundamental role in the development of mitochondrial diseases. Furthermore, in mammals, the integrated stress response (ISR) and UPRmt are strongly coupled, functioning together to maintain mitochondrial function. Therefore, ISR and UPRmt show great application prospects in the treatment of mitochondrial diseases. In this review, we provide an overview of the molecular mechanisms of ISR and UPRmt and focus on them as potential targets for mitochondrial disease therapy. Full article
Show Figures

Figure 1

Back to TopTop